GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » IMS Health Holdings Inc (NYSE:IMS) » Definitions » EBITDA

IMS Health Holdings (IMS Health Holdings) EBITDA : $714 Mil (TTM As of Jun. 2016)


View and export this data going back to 2014. Start your Free Trial

What is IMS Health Holdings EBITDA?

IMS Health Holdings's EBITDA for the three months ended in Jun. 2016 was $166 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Jun. 2016 was $714 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

IMS Health Holdings's EBITDA per Share for the three months ended in Jun. 2016 was $0.50. Its EBITDA per share for the trailing twelve months (TTM) ended in Jun. 2016 was $2.12.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


IMS Health Holdings EBITDA Historical Data

The historical data trend for IMS Health Holdings's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMS Health Holdings EBITDA Chart

IMS Health Holdings Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EBITDA
Get a 7-Day Free Trial 608.00 638.00 694.00 377.00 727.00

IMS Health Holdings Quarterly Data
Dec10 Dec11 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.00 182.00 170.00 196.00 166.00

Competitive Comparison of IMS Health Holdings's EBITDA

For the Health Information Services subindustry, IMS Health Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMS Health Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, IMS Health Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where IMS Health Holdings's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

IMS Health Holdings's EBITDA for the fiscal year that ended in Dec. 2015 is calculated as

IMS Health Holdings's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2015, IMS Health Holdings's EBITDA was $727 Mil.

IMS Health Holdings's EBITDA for the quarter that ended in Jun. 2016 is calculated as

IMS Health Holdings's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Jun. 2016, IMS Health Holdings's EBITDA was $166 Mil.

EBITDA for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $714 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

IMS Health Holdings  (NYSE:IMS) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


IMS Health Holdings EBITDA Related Terms

Thank you for viewing the detailed overview of IMS Health Holdings's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


IMS Health Holdings (IMS Health Holdings) Business Description

Traded in Other Exchanges
N/A
Address
IMS Health Holdings Inc was formed on October 23, 2009 in Delaware. The Company is an information and technology services company. It provides clients in the healthcare industry with comprehensive solutions to measure and improve their performance. It has collections of healthcare information, spanning sales, prescription and promotional data, medical claims, electronic medical records and social media. The Company provides service to healthcare organizations and decision makers around the world, spanning the breadth of life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company offers various information offerings developed to meet its clients' needs by using data secured from network of suppliers. The Company's offerings compete with various firms, including Accenture, Cognizant Technology Solutions, Covance, Deloitte, Evidera, GfK, Health Market Science, IBM, Infosys, inVentiv Health, Kantar Health, McKinsey, Nielsen, OptumInsight, Parexel, Press Ganey, Quintiles, RTI Health Solutions, Symphony Health Solutions, Synovate Healthcare, The Advisory Board, Trizetto, Verisk and ZS Associates. The Company has trademarks and service marks that it uses in connection with the operation of its business, including IMS Health, IMS, the IMS logo, IMS One, MIDAS, Xponent, DDD, AppScript, AppNucleus, MD360 Provider Performance Management and Evidence360.
Executives
Michael R Mcdonnell officer: EVP and CFO C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
David Bonderman other: Former 10% Owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Lgp Associates V Llc director 11111 SANTA MONICA BLVD., SUITE 2000, LOS ANGELES CA 90025
Peridot Coinvest Manager Llc director 11111 SANTA MONICA BOULEVARD, LOS ANGELES CA 90025
Green V Holdings, Llc director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Green Equity Investors V, L.p. director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Green Equity Investors Side V, L.p. director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Gei Capital V, Llc director 11111 SANTA MONICA BOULEVARD, SUITE 2000, LOS ANGELES CA 90025
Sharad Mansukani director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Lgp Management Inc director 11111 SANTA MONICA BLVD, STE 2000, LOS ANGELES CA 90025
Leonard Green & Partners, L.p. director 11111 SANTA MONICA BLVD, STE 2000, LOS ANGELES CA 90025
Jim Fasano director 83 WOOSTER HEIGHTS, DANBURY CT 06810
Cpp Investment Board Private Holdings, Inc. 10 percent owner ONE QUEEN STREET EAST,, SUITE 2500, TORONTO A6 M5C 2W5
Canada Pension Plan Investment Board 10 percent owner ONE QUEEN STREET EAST, STE 2500, TORONTO ONTARIO A6 0000
Kevin C Knightly officer: SVP, Information Offerings 1499 POST ROAD, FAIRFIELD CT 06824

IMS Health Holdings (IMS Health Holdings) Headlines

From GuruFocus

5 Companies Reach 52-Week Highs

By yifan900 yifan900 02-13-2018

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson 10-23-2015

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao 08-11-2015

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li 08-16-2016

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 10-11-2016